Synaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
https://european-biotechnology.com/wp-content/uploads/2024/04/EBM322_Pascal_Bricout_kl.jpg822731Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2022-09-06 12:37:002024-07-16 17:42:18New Head of Finance for Carbios
https://european-biotechnology.com/wp-content/uploads/2024/04/BioEcho-Boston-_6553739_7_2022_06.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-09-02 09:34:002024-04-04 16:45:57BioEcho Life Sciences launches US subsidiary
Researchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects.
A small prospective study among mid-aged people has demonstrated that a mild SARS-CoV-2 infection triggers ME/CF in 50% of the study population.<button lang="en-GB" aria-description="Klicken, um Alternative zu verwenden"> </button>
Swedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections.
Emergence Therapeutics licences Synaffix platform
Latest NewsSynaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
New Head of Finance for Carbios
AppointmentsFinance Expert Pascal Bricout strengthens French Carbios as Chief of Strategy; Financial Officer and a member of the Executive Committee.
Abivax SA bags €49.2m to push ABX-464
Latest NewsParis-based Abivax SA has cashed in €49.2m in an oversubscribed financing with top-tier US and European biotech investors.
BioEcho Life Sciences launches US subsidiary
Latest NewsGerman nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market.
Belgian researchers create extraembryonic mesoderm cells
Latest NewsResearchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects.
SARS-CoV-2 infection triggers chronic fatigue syndrome
Latest NewsA small prospective study among mid-aged people has demonstrated that a mild SARS-CoV-2 infection triggers ME/CF in 50% of the study population.<button lang="en-GB" aria-description="Klicken, um Alternative zu verwenden">
</button>
Danish Bactolife A/S grabs funding
Latest NewsSwedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections.
Moderna launches patent dispute with BioNTech/Pfizer
Latest NewsFor the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement.
Belgian eTheRNA raises €39m in Series B2 financing
Latest NewsModerna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a €39m Series B2 financing in eTheRNA.
Kinarus announces CHF 20 million convertible bond issue
Latest NewsKinarus Therapeutics Holding AG has raised US$20m in financing through the issuance of convertible bonds to YA II PN, Ltd.